Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues

Journal of Gene Medicine

Volumn 5, Issue 7, 2003, Pages 560-566

  Tarkka, Tatu ^b   Sipola, Annina ^a   Jämsä, Timo ^a   Soini, Ylermi ^a   Ylä Herttuala, Seppo ^c   Tuukkanen, Juha ^a   Hautala, Timo ^a  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bone defect; Endochondral; Intramembranous; Osteogenesis

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; VASCULOTROPIN A; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DEFECT; BONE INJURY; BONE MINERAL; BONE TISSUE; CARTILAGE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; ENCHONDRAL OSSIFICATION; FEMUR; FRACTURE HEALING; GENE OVEREXPRESSION; GENE TRANSFER; MALE; NONHUMAN; PERIOSTEUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STATISTICAL SIGNIFICANCE; TISSUE REPAIR; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; BONE; BONE DENSITY; BONE DEVELOPMENT; FEMUR FRACTURE; GENE THERAPY; GENE VECTOR; GENETICS; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; BONE AND BONES; BONE DENSITY; FEMORAL FRACTURES; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0344289637     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.392     Document Type: Article

References (39)

1. Collin-Osdoby P. Role of vascular endothelial cells in bone biology. J Cell Biochem 1994; 55: 304-309.
2. Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129: 1893-1904.
3. Pufe T, Wildemann B, Petersen W, et al. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 2002; 309: 387-392.
4. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002; 110: 751-759.
5. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone remover. Proc Natl Acad Sci U S A 2002; 99 9656-9661.
6. Carlevaro MF, Cermelli S, Cancedda R, et al. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000; 113: 59-69.
7. Wang DS, Miura M, Demura H, et al. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997; 138: 2953-2962.
8. Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30: 472-477.
9. Deckers MM, Karperien M, van Der BG, et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000; 141: 1667-1674.
10. Nakagawa M, Kaneda T, Arakawa T, et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000; 473: 161-164.
11. Deckers MM, van Bezooijen RL, van Der HG, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143 1545-1553.
12. Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am 1991; 73: 832-847.
13. Hauge EM, Qvesel D, Eriksen EF, et al. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16: 1575-1582.
14. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-628.
15. Engsig MT, Chen Q J, Vu TH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000; 151: 879-889.
16. Vu TH, Shipley JM, Bergers G, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411-422.
17. Wang DS, Yamazaki K, Nohtomi K, et al. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996; 11: 472-479.
18. Spector JA, Mehrara BJ, Luchs JS, et al. Expression of adenovirally delivered gene products in healing osseous tissues. Ann Plast Surg 2000; 44: 522-528.
19. Baltzer AW, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000; 7: 734-739.
20. Baltzer AW, Lattermann G, Whalen JD, et al. A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealand white rabbit model. Knee Surg Sports Traumatol Arthrosc 1999; 7: 197-202.
21. Niyibizi C, Baltzer A, Lattermann G, et al. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 1998; S148-S153.
22. Mason JM, Grande DA, Barcia M, et al. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther 1998; 5: 1098-1104.
23. Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth-factor during embryonic angiogenesis and endothelial-cell differentiation. Development 1992; 114: 521-532.
24. Laitinen M, Makinen K, Manninen H, et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9: 1481-1486.
25. Puumalainen AM, Vapalahti M, Agrawal RS, et al. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther 1998; 9: 1769-1774.
26. Rissanen TT, Markkanen JE, Arve K, et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 2003; 17: 100-102.
27. Vajanto I, Rissanen TT, Rutanen J, et al. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med 2002; 4: 371-380.
28. Jamsa T, Viluksela M, Tuomisto JT, et al. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures. J Bone Miner Res 2001; 16: 1812-1820.
29. Uusitalo H, Rantakokko J, Ahonen M, et al. A metaphyseal defect model of the femur for studies of murine bone healing. Bone 2001; 28: 423-429.
30. Matsumoto Y, Tanaka K, Hirata G, et al. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol 2002; 168: 5824-5831.
31. Collin-Osdoby P, Rothe L, Anderson F, et al. Receptor activator of NF-kappa Band osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001; 276 20 659-20 672.
32. Doherty MJ, Canfield AE. Gene expression during vascular pericyte differentiation. Crit Rev Eukaryot Gene Expr 1999; 9 1-17.
33. Horner A, Bishop NJ, Bord S, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 1999; 194: 519-524.
34. Cao B, Mytinger JR, Huard J. Adenovirus mediated gene transfer to skeletal muscle. Microsc Res Tech 2002; 58: 45-51.
35. Ylä-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.
36. Okubo Y, Bessho K, Fujimura K, et al. The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector. Life Sci 2001; 70: 325-336.
37. Nalbantoglu J, Larochelle N, Wolf E, et al. Muscle-specific overexpression of the adenovirus primary receptor GAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol 2001; 75: 4276-4282.
38. Street JT, Wang JH, Wu QD, et al. The angiogenic response to skeletal injury is preserved in the elderly. J Orthop Res 2001; 19: 1057-1066.
39. Pufe T, Petersen W, Tillmann B, et al. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001; 44: 1082-1088.